Arc Health (06086) rose over 17% during the session, and as of this writing, is up 13.36%, priced at 5.77 Hong Kong dollars, with a transaction volume of 0.138 billion Hong Kong dollars.
According to Zhiyu Finance APP, Ark Health (06086) rose over 17% during the day, and as of the time of publication, it increased by 13.36%, priced at 5.77 HKD, with a transaction volume of 0.138 billion HKD.
Recently, Wisdom Eye and Huawei jointly released the first fully domesticated intelligent solution in the Medical Industry, the "Bian Stone + DeepSeek Dual-Engine Medical Intelligence Integrated Machine." Zheshang stated that AI giants like NVIDIA and Microsoft are actively laying out in the medical field and are Bullish on the future of AI medical development. It is reported that in February this year, Ark Health announced the integration of the DeepSeek open-source large model and completed the privatization deployment. The optimization of technology and computing power provides a digital drive for "AI + Chronic Disease Management." Ark Health aims to upgrade to "AI + H2H (Hospital To Home)" through its independently developed smart medical ecosystem, hoping to become a new growth point in the company’s smart medical Business.
Looking ahead, Ark Health plans to focus on the development of multiple "AI Intelligent Assistant" scenarios by 2025 to promote application landing. The company will increase R&D investment, leveraging advanced models like DeepSeek to explore the value of medical data and create exclusive "Digital Employees" and "Intelligent Solutions" for the pharmaceutical industry, pushing Digital Health towards a more professional, efficient, and intelligent direction. It is also worth mentioning that Ark Health has recently been included in the Hong Kong Stock Connect list, and the company will release its 2024 annual performance today.
